A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)
Clinical trial NCT05939648 · UNKNOWN
Trial details
- NCT number
- NCT05939648
- Sponsor
- AIM Vaccine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-09
- Primary completion
- 2023-11-30
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.